New England Biolabs (United States)
New England Biolabs is an American life sciences company which produces and supplies recombinant and native enzyme reagents for life science research. It also provides products and services supporting genome editing, synthetic biology and next-generation sequencing. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for New England Biolabs (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
72%
Total
Publications
1.8K
Total Open
Publications
1.3K
Total
Citations
110K
Open Access
Percentage
72%
Total
Publications
1.8K
Total Open
Publications
1.3K
Total
Citations
110K
Breakdown
Publisher Open
13%
Both
45%
Other Platform Open
14%
Closed
28%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 71%
740
Hybrid 16%
166
No Guarantees 13%
138
Other Platform Open
Domain 63%
674
Other Internet 29%
307
Institution 17%
182
Preprint 11%
113
Public 6%
67
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 669 |
DOI | Other Internet | 304 |
bioRxiv | Preprint | 96 |
Europe PMC | Domain | 78 |
Figshare | Public | 68 |
Office of Scientific and Technical Information | Institution | 57 |
Harvard University | Institution | 34 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 27 |
Royal Netherlands Academy of Arts and Sciences | Institution | 10 |
King's College London | Institution | 10 |